These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 25487669

  • 1. Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Ishikura K, Hataya H, Honda M, Nozu K, Iijima K, Shima Y, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Group.
    Pediatr Nephrol; 2015 Jun; 30(6):961-7. PubMed ID: 25487669
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
    [Abstract] [Full Text] [Related]

  • 3. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [Abstract] [Full Text] [Related]

  • 4. Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
    Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    Pediatr Nephrol; 2019 May; 34(5):837-846. PubMed ID: 30284023
    [Abstract] [Full Text] [Related]

  • 5. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Katafuchi R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y, Study Group Special IgA Nephropathy.
    J Nephrol; 2013 May; 26(2):350-7. PubMed ID: 22684645
    [Abstract] [Full Text] [Related]

  • 6. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [Abstract] [Full Text] [Related]

  • 8. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2017 Nov; 955():65-73. PubMed ID: 27718216
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

  • 10. The impact of sex in primary glomerulonephritis.
    Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [Abstract] [Full Text] [Related]

  • 11. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y, Liu JC, Xiao HJ, Huang JP, Yang JY.
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [Abstract] [Full Text] [Related]

  • 12. Effect and therapeutic mechanisms of tonsillectomy for childhood IgA nephropathy.
    Nishi H, Sugimoto K, Fujita S, Miyazaki K, Miyazawa T, Sakata N, Okada M, Takemura T.
    Nephrology (Carlton); 2012 Sep; 17(7):658-64. PubMed ID: 22616843
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
    Yoshikawa N, Nakanishi K, Ishikura K, Hataya H, Iijima K, Honda M, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2008 May; 23(5):757-63. PubMed ID: 18224343
    [Abstract] [Full Text] [Related]

  • 14. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

  • 15. Prognostic indicators and treatment of childhood IgA nephropathy.
    Hogg RJ.
    Contrib Nephrol; 1995 Feb; 111():194-9; discussion 199-200. PubMed ID: 7758342
    [No Abstract] [Full Text] [Related]

  • 16. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
    Komatsu H, Sato Y, Miyamoto T, Tamura M, Nakata T, Tomo T, Nishino T, Miyazaki M, Fujimoto S.
    Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429
    [Abstract] [Full Text] [Related]

  • 17. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 18. Epidemiological survey and clinical investigation of pediatric IgA nephropathy.
    Shibano T, Takagi N, Maekawa K, Mae H, Hattori M, Takeshima Y, Tanizawa T.
    Clin Exp Nephrol; 2016 Feb; 20(1):111-7. PubMed ID: 26041644
    [Abstract] [Full Text] [Related]

  • 19. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
    Shen XH, Liang SS, Chen HM, Le WB, Jiang S, Zeng CH, Zhou ML, Zhang HT, Liu ZH.
    J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
    [Abstract] [Full Text] [Related]

  • 20. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Aug; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.